To access this element change to forms mode OFF
Grant Award View - GA66021
A novel therapeutic strategy for lymphoedema
GA ID:
GA66021
Agency:
National Health and Medical Research Council (NHMRC)
Approval Date:
12-Nov-2019
Publish Date:
16-Dec-2019
Category:
Health and Medical Research
Grant Term:
1-Jan-2020 to 31-Dec-2022
Value (AUD):
$708,880.00
(GST inclusive where applicable)
One-off/Ad hoc:
No
Aggregate Grant Award:
No
PBS Program Name:
NHMRC 18/19 1.1 Health and Medical Research
Grant Program:
Ideas
Grant Activity:
A novel therapeutic strategy for lymphoedema
Purpose:
Lymphoedema is a common chronic disease which, in Australia, predominantly occurs in women. There are no effective preventative strategies for lymphoedema, current treatments are of limited benefit and there are no drug-based therapeutics for the condition. This project will validate a new way of treating lymphoedema based on drugs that target key molecular signalling mechanisms in this disease. This approach will also be tested for its capacity to prevent lymphoedema.
GO ID:
GO Title:
Ideas Grants 2019
Internal Reference ID:
GNT1183926
Selection Process:
Targeted or Restricted Competitive
Confidentiality - Contract:
Yes
Confidentiality Reason(s) - Contract:
Privacy Act 1988
Intellectual property
Intellectual property
Confidentiality - Outputs:
Yes
Confidentiality Reason(s) - Outputs:
Intellectual property
Grant Recipient Details
Recipient Name:
University of Melbourne
Recipient ABN:
84 002 705 224
Grant Recipient Location
Suburb:
Parkville
Town/City:
Parkville
Postcode:
3052
State/Territory:
VIC
Country:
AUSTRALIA
Grant Delivery Location
State/Territory:
VIC
Postcode:
Country:
AUSTRALIA